AveloMask Kit TB Study Results Presented at the Union Conference in Copenhagen

November 21, 2025. Avelo is pleased to share that partners from the CLIME Research Group at Stellenbosch University presented the latest AveloMask Kit tuberculosis (TB) study results today at the Union Conference in Copenhagen, a leading global forum for TB and the world’s largest conference on lung health.

A short video summarizing the study results is available here:

The study showcases the feasibility and diagnostic potential of capturing Mycobacterium tuberculosis from exhaled breath using the AveloMask Kit, offering a simple, non-invasive alternative to sputum collection and supporting improved identification of individuals more likely to be infectious.

Avelo extends its gratitude to Rouxjeane Venter, the entire CLIME team for their leadership in presenting and advancing this important work toward safer, more accessible TB diagnosis.

About Avelo

Avelo AG, the Swiss breath sampling company, aims to revolutionize the diagnosis of tuberculosis and lower respiratory tract infections causing pneumonia. Its breath collection device enables non-invasive collection of pathogens from breath aerosols and works with existing PCR tests. The novel device is designed for broad utility, similar to other sample collection technologies such as blood tubes.